Bengaluru-based healthtech startup Dozee is set to raise $10 million (₹86 crore) in debt funding from Stockhausen International Pte Ltd, marking its second debt infusion in four months after a $7 million raise in March 2025.
According to regulatory filings with the Registrar of Companies, the board approved issuing 7,545 Series B optionally convertible debentures at a face value of ₹1,14,074 each to secure the funding. The capital will be used for business operations, product development, and lending to overseas subsidiaries. Founded in 2015, Dozee specializes in Remote Patient Monitoring (RPM) and Early Warning Systems (EWS). Its products include Shravan, an AI-powered early hearing screening and rehabilitation device, and a smart mat that sits under a mattress to monitor vital signs such as heart rate, respiration, stress, and sleep patterns.
The company recently earned the CE Mark under EU MDR 2017/745, a global standard for medical device safety and efficacy. Backed by Prime Venture Partners, Dozee has raised about $38 million to date from investors including Yournest and 3One4 Capital.
Also Read: The Rise of True Meds: Affordable Medicines for Every Indian
